Teva Pharmaceutical Industries Ltd., which just two years ago was analysts’ highest-rated stock among the world’s 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy will revive growth.
Among defense contractors, QinetiQ North America is known for spy-world connections and an eye- popping product line. Its contributions to national security include secret satellites, drones, and software used by U.S. special forces in Afghanistan and the Middle East.
The White House may have difficulty bolstering U.S. cyber defenses through an executive order unless there’s enough public support, according to former National Security Agency director Michael Hayden.
Sept. 30 (Bloomberg) -- Former CIA Director Michael Hayden talks about cyber security issues facing the U.S., Marion Blakey, president of the Aerospace Industries Association, discusses the need to avoid automatic cuts to U.S. defense spending. Bloomberg Government's Nela Richardson and Cady North report on financial regulation and the Volcker Rule. They speak with Peter Cook on Bloomberg Government's "Capitol Gains," which airs on Bloomberg Television. (Source: Bloomberg)
Teva Pharmaceutical Industries Ltd. will test its experimental multiple-sclerosis pill in combination therapies as the company mounts a response to oral competitors to its best-selling injection Copaxone.
Teva Pharmaceutical Industries Ltd. will focus drug-development efforts under new Chief Executive Officer Jeremy Levin on respiratory and central nervous system illnesses as the company seeks to replace medicines set to lose patent protection in the next three years.
Teva Pharmaceutical Industries Ltd. ended an alliance with an Israeli biotechnology company for the development of an experimental cancer drug as Chief Executive Officer Jeremy Levin narrows the company’s research focus.